🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsSemaglutide fatty acid sidechain — 12 month update Page 8

Semaglutide fatty acid sidechain — 12 month update

SaraMom3 Wed, Sep 11, 2024 at 3:09 PM 36 replies 2,367 viewsPage 8 of 8
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Sep 27, 2024 at 5:14 PM#36
kate.chem said:
One habit that pays for itself: post the method alongside the number.

Pushing back on kate.chem here. Filing an objection on the n=1 problem. Personal experience is genuine evidence about one person and very weak evidence about anybody else, and this thread keeps promoting the first into the second.

Last edited: Sep 27, 2024 at 11:14 PM
11 9Dr.LipidDallas, alex_tucson, kevin_tulsa and 8 others
Reply Quote Save Share Report
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Sep 28, 2024 at 5:51 AM#37
kate.chem said:
One habit that pays for itself: post the method alongside the number.

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

12 10KristenIndy, MarkLI_maint, Dr.PeteFamMed and 9 others
Reply Quote Save Share Report
RunnerRach
Member
467
2,123
Aug 2024
Boston, MA
Sep 28, 2024 at 6:27 PM#38
kate.chem said:
One habit that pays for itself: post the method alongside the number.

Saving this. It is the first explanation that did not require me to already understand it.

13 11Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 10 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Sep 29, 2024 at 7:03 AM#39

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

That is the short version; the long version is somebody else's post.

14 12TomFromTexas, mike.trainer_LA, sarah_nash92 and 11 others
Reply Quote Save Share Report
SkepticalSean
Member
98
345
Jan 2025
Maine
Sep 29, 2024 at 7:39 PM#40
Dr.AddMedPHL said:
The useful move here is to separate what is established from what is widely repeated.

Second this.

36 9Dr.LipidDallas, alex_tucson, kevin_tulsa and 33 others
Reply Quote Save Share Report
1678

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register